Abstract
Background and objective
The educational aspect of oral anticoagulant treatment is considered a possible cause of variability in anticoagulation levels. The aim of this prospective study was to investigate whether the time spent in the therapeutic range (TSTR) by patients taking oral anticoagulants could be improved by two different, consecutive educational approaches on the crucial aspects of oral anticoagulant therapy.
Design and methods
Between May and June 2004, validated interviews were conducted with 240 patients (128 male and 112 female, mean age 50 ± 12 years) enrolled in the study. Three months later, the patients were randomly allocated to three groups. A course that focused on the questions in the interview was followed by the first group (n = 80); a brochure containing the correct answers to questions was given to the second (n = 81); nothing was provided for the third (n = 79).
Results
A significant difference was found in the TSTR between the quarters preceding and following the interview. Mean TSTR increase was 13%. Patients that were randomly selected to attend the educational course, read a brochure or do nothing showed similar TSTR percentages in the quarter following the interview. A good control of the anticoagulant therapy (TSTR >70%) was maintained, with no significant variation during the following three-quarters.
Interpretation and conclusions
A two-step educational approach for patients on long-term oral anticoagulation does not improve TSTR percentages in the short term.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Guida alla terapia con anticoagulanti orali (2006) Raccomandazioni della Federazione dei Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA). Terzo accordo generale della Federazione. V Edizione
Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complication of Oral Anticoagulant Therapy. Lancet 348:423–428
Palareti G, Manotti C, D’Angelo A et al (1997) Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study. Thromb Haemost 78:1438–1443
Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) Chest 126:204S–233S
Wells PS, Holbrook AM, Crowther NR, Hirsh J (1994) Interaction of warfarin with drugs and food. Ann Intern Med 121:676–683
Marongiu F, Sorano GG, Conti M, Mameli G, Biondi G, Balestrieri A (1992) A known vitamin K intake and management of poorly controlled oral anticoagulant therapy. Lancet 340:545–546
Booth SL, Charnley JM, Sadowski JA, Saltzman E, Bovill EG, Cushman M (1997) Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. Thromb Haemost 77:504–509
Manotti C, Quintavalla R, Pattacini C, Pini M (1994) Seasonal variation of oral anticoagulant effect. Thromb Haemost 71:802–803
Kumar S, Haigh JR, Rhodes LE et al (1989) Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 62:729–732
McCormick D, Gurwitz JH, Goldberg RJ et al (2001) Prevalence and quality of warfarin use in patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458–2463
Cortellazzo S, Finazzi G, Viero P et al (1993) Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 69:316–320
Aithal GP, Day CP, Kesteven PJL, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717–719
Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd CJ (2000) Anticoagulant patient information material is written at high readability levels. Stroke 31:2966–2970
Barcellona D, Contu P, Marongiu F (2002) Patient education and oral anticoagulant therapy. Haematologica 87:1081–1086
Manotti C, Moia M, Palareti G, Pengo V, Ria L, Dettori AG (2001) Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment). Haematologica 86:1060–1070
Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–237
Palareti G, Legnani C, Guazzaloca G, et al on behalf of the ad hoc study group of the Italian Federation of Anticoagulation Clinics (2005) Risks factors for highly unstable response to oral anticoagulation: a case–control study. Br J Haematol 129:72–78
Laporte S, Quenet S, Buchmuller-Cordier A et al (2003) Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 89:458–467
Barcellona D, Fenu L, Marongiu F (2003) Oral anticoagulant therapy: should doctors change the way they give patients explanations?Thromb Haemost 90:159–160
Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F (2000) The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 83:49–53
Marongiu F, Barcellona D (2005) The future of anticoagulation clinics: a journey to thrombosis centres?Haematologica/THJ 90:298–301
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barcellona, D., Contu, P. & Marongiu, F. A “two-step” educational approach for patients taking oral anticoagulants does not improve therapy control. J Thromb Thrombolysis 22, 185–190 (2006). https://doi.org/10.1007/s11239-006-9027-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-006-9027-2